skip to main content
Show Results with:

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page
Refined by: subject: Cancer--Periodicals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy—Summary of Advances and Future Directions for Studying These Drugs

Loo, Kimberly; Daud, Adil I.

The cancer journal. Volume 23:Issue 1 (2017, January/February); pp 3-9 -- Lippincott, Williams & Wilkins

Online access

2
Material Type:
Article
Add to My workspace

Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy—Summary of Advances and Future Directions for Studying These Drugs

Loo, Kimberly; Daud, Adil I.

The cancer journal. Volume 23:Issue 1 (2017) -- Lippincott, Williams & Wilkins

Online access

3
Material Type:
Article
Add to My workspace

Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours

Schöffski, Patrick et al.

European journal of cancer. Volume 86: (2017, November); pp 296-304 -- Elsevier

Online access

4
Material Type:
Article
Add to My workspace

Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours

Schöffski, Patrick et al.

European journal of cancer. Volume 86 (2017); pp 296-304 -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

Grob, Jean Jacques et al.

European journal of cancer. Volume 91 (2018); pp 168-170 -- Elsevier

Online access

6
Material Type:
Article
Add to My workspace

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Hamid, Omid et al.

British journal of cancer. Volume 119:Issue 6 (2018); pp 670-674 -- Springer Nature

Online access

7
Material Type:
Article
Add to My workspace

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

Grob, Jean Jacques et al.

European journal of cancer. Volume 91: (2018, March); pp 168-170 -- Elsevier

Online access

8
Material Type:
Article
Add to My workspace

Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies

Algazi, Alain P. et al.

Cancer. Volume 122:Issue 21 (2016); pp 3344-3353 -- Published for the American Cancer Society by J. Wiley

Online access

9
Material Type:
Article
Add to My workspace

Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial

Carlino, Matteo S. et al.

European journal of cancer. Volume 101 (2018); pp 236-243 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Hamid, Omid et al.

European journal of cancer. Volume 86: (2017, November); pp 37-45 -- Elsevier

Online access

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Creation date 

From To

Additional Features 

  1. Abstract  (12)
  2. No Abstract  (2)
  3. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Daud, Adil
  2. Robert, Caroline
  3. Schadendorf, Dirk
  4. Ribas, Antoni
  5. Ebbinghaus, Scot

Searching Remote Databases, Please Wait